Learning from Leading through Upheaval
Zoom in on this interactive session with biopharma leaders from across the industry
As biopharma R&D faces interlocking crises of COVID-19, economic dislocation, and social inequality, we have never needed community more. Kummer Consulting offers this free, interactive knowledge exchange over Zoom to share what we’ve learned about leadership while navigating a chaotic new world.
Read about our successful first session and get inspired.
You will:
- Build lessons for the future.
- Step back from the everyday stress.
- Generate insights about leading R&D teams in the face of global upheaval.
- Discover you’re not alone.
Participation is free but pre-registration is required.
Date: July 21, 2020
Time: 2:00-3:00 PM EDT
Location: Wherever you are
Agenda
I. Introduction
II. Knowledge Exchange
- Reflection: Leading during crisis
- Roundtable: Thrust into the unknown
- Lessons: Learning from experience
III. Synthesis: Facing the future
- Leadership for a rapidly changing world
Program Team
Merle Kummer MBA, Principal, Kummer Consulting, has taught hundreds of life science professionals how to succeed as R&D leaders. Participants find the learning transformational for their careers, and many of them now play senior management roles for rising biotechs. Merle’s enthusiasm and dedication bring program participants year after year to learn new approaches for challenges at the cutting edge of science and medicine.
Liz Bloss DVM, Co-Founder and Managing Partner of The Bracken Group, brings a 25-year track record of delivering regulatory success at leading companies including Sanofi, Novo Nordisk, Kyowa Hakko Kirin, and GE Medical. An exceptional cross-functional leader, she brings discipline and organizational clarity to build committed teams delivering innovative solutions for complex submissions.
Nerissa Kreher MD, Chief Medical Officer, Tiburio Therapeutics, an accomplished physician executive and pediatric endocrinologist, has held leadership roles in both private biotechnology start-ups and large public biotech companies. Her expertise is in the development of products for rare diseases spanning multiple therapeutic areas, bringing more than a decade of experience in Clinical Development and Medical Affairs.
Aileen Morgan MBA, Head of Program Management, Avanir Pharmaceuticals, has over 35 years of experience both in the UK and the US in team leadership, clinical development, product development, and manufacturing. Her passion is bringing teams together to develop products that will make a difference for patients.
J. Fred Pritchard, Ph.D. Vice President, Strategic Development, Celerion, focuses on strategic growth and investment to meet the evolving needs of early clinical drug development. He leads and mentors a global team of drug development and regulatory affairs experts that work collaboratively with clients to bring their drug products efficiently through early clinical testing. He brings over 35 years of drug development experience, including leading international teams of scientists at large pharmaceutical companies as well as virtual groups of experts to support smaller entrepreneurial drug developers.
Tina Szafoni MS MBA, Head of Learning Ops, Product Development, Clinical Operations at Genentech, brings over 25 years of drug development experience in a variety of leadership roles from lab bench to leading project teams and functional organizations. She leverages her expertise as a certified project manager, scrum master, change manager and corporate coach to build professional development programs and improve the success of drug development teams.